Cargando…

Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12)

AIM: To investigate risk factors associated with kidney disorders in patients with type 2 diabetes (T2D) at high cardiovascular (CV) risk. METHODS: In DEVOTE, a cardiovascular outcomes trial, 7637 patients were randomised to insulin degludec (degludec) or insulin glargine 100 units/mL (glargine U100...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amod, Aslam, Buse, John B, McGuire, Darren K, Pieber, Thomas R, Pop-Busui, Rodica, Pratley, Richard E, Zinman, Bernard, Hansen, Marco Bo, Jia, Ting, Mark, Thomas, Poulter, Neil R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919227/ https://www.ncbi.nlm.nih.gov/pubmed/33280425 http://dx.doi.org/10.1177/1479164120970933

Ejemplares similares

Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11)
por: Amod, Aslam, et al.
Publicado: (2019)

Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)
por: Brown‐Frandsen, Kirstine, et al.
Publicado: (2019)

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality
por: Pieber, Thomas R., et al.
Publicado: (2017)

Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
por: Zinman, Bernard, et al.
Publicado: (2017)

Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)
por: Pratley, Richard E., et al.
Publicado: (2019)

Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE
por: Heller, Simon, et al.
Publicado: (2020)

Development of a hypoglycaemia risk score to identify high‐risk individuals with advanced type 2 diabetes in DEVOTE
por: Heller, Simon, et al.
Publicado: (2020)

Heart failure with insulin degludec versus glargine U100 in patients with type 2 diabetes at high risk of cardiovascular disease: DEVOTE 14
por: Pratley, Richard E., et al.
Publicado: (2019)

Hemoglobin glycation index, calculated from a single fasting glucose value, as a prediction tool for severe hypoglycemia and major adverse cardiovascular events in DEVOTE
por: Klein, Klara R, et al.
Publicado: (2021)

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
por: Buse, John B., et al.
Publicado: (2020)

Short‐term cost‐utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9)
por: Pollock, Richard F., et al.
Publicado: (2019)

Devotion
por: McLaughlin, John, 1942-
Publicado: (1992)

Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE, LEADER and SUSTAIN‐6 cardiovascular outcomes trials
por: Kahkoska, Anna R., et al.
Publicado: (2020)

Devotion to Duty
Publicado: (1906)

Cardiac Autonomic Neuropathy in Diabetes: A clinical perspective
por: Pop-Busui, Rodica
Publicado: (2010)

Devotion for newborn children
por: Purcarea, VL
Publicado: (2016)

Response to Comment on Lachin et al. Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial. Diabetes Care 2017;40:777–783
por: Lachin, John M., et al.
Publicado: (2017)

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial
por: Lachin, John M., et al.
Publicado: (2017)

Long-term Cost-effectiveness of Insulin Degludec Versus Insulin Glargine U100 in the UK: Evidence from the Basal-bolus Subgroup of the DEVOTE Trial (DEVOTE 16)
por: Pollock, Richard F., et al.
Publicado: (2019)

Devotions upon emergent occasions
Publicado: (1977)

Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials
por: Verma, Subodh, et al.
Publicado: (2020)

Response to Comment on Jaiswal et al. Prevalence of and Risk Factors for Diabetic Peripheral Neuropathy in Youth With Type 1 and Type 2 Diabetes: SEARCH for Diabetes in Youth Study. Diabetes Care 2017;40:1226–1232
por: Jaiswal, Mamta, et al.
Publicado: (2018)

The Ordinary Devoted Mother and Her Baby
Publicado: (1950)

Ramadan: devotion, compassion, and purification in Sydney
por: Possamai, Adam, et al.
Publicado: (2022)

NIV women's devotional Bible : New International Version.
Publicado: (1990)

Hopefully devoted to Q: targeting glutamine addiction in cancer
por: Still, Emma R, et al.
Publicado: (2017)

In TFIIH, XPD Helicase Is Exclusively Devoted to DNA Repair
por: Kuper, Jochen, et al.
Publicado: (2014)

Triglycerides and Amputation Risk in Patients With Diabetes: Ten-year follow-up in the DISTANCE study
por: Callaghan, Brian C., et al.
Publicado: (2011)

Correction: Hopefully devoted to Q: targeting glutamine addiction in cancer
por: Still, Emma R., et al.
Publicado: (2019)

Increased Derived Time in Range Is Associated with Reduced Risk of Major Adverse Cardiovascular Events, Severe Hypoglycemia, and Microvascular Events in Type 2 Diabetes: A Post Hoc Analysis of DEVOTE
por: Bergenstal, Richard M., et al.
Publicado: (2023)

Long‐term efficacy and safety of combined insulin and glucagon‐like peptide‐1 therapy: Evidence from the LEADER trial
por: Tack, Cees J., et al.
Publicado: (2019)

Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis
por: Mann, Johannes F. E., et al.
Publicado: (2021)

Neuropathy and Related Findings in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
por: Martin, Catherine L., et al.
Publicado: (2014)

Hypoglycemia unawareness and autonomic dysfunction in diabetes: Lessons learned and roles of diabetes technologies
por: Lin, Yu Kuei, et al.
Publicado: (2020)

Special Public Meeting devoted to Associated Members of personnel
por: Staff Association
Publicado: (2022)

Constant dedication, passion and devotion for the patients with neurological affections
por: Purcarea, VL
Publicado: (2015)

Inpatient psychiatry unit devoted to COVID-19 patients
por: Mahgoub, Nahla, et al.
Publicado: (2021)

Elisa Estenssoro: a career devoted to critical care
por: Kirby, Tony
Publicado: (2021)

North-Western Educator: Devoted to Education, Liter., &c.
Publicado: (1847)

Abstract 4: Derived time-in-range is associated with major adverse cardiovascular event in T2D: Data from the DEVOTE trial
por: Pathan, Muzammil Khan A, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5h5i5c4c0ecfo86hdq3sq3opq3